Browse News

Found 7,522 articles

• 

  Biogen Expected to Cut Costs by $1B as Industry Braves Economic Instability

  8/11/2022

  Biogen expects to lay off a potential 1,000 staffers in an effort to cut about $1 billion in costs, according to The Boston Globe, while 10x Genomics and Talis Biomedical also cut staff.

• Bioventus Reports Second Quarter Results; Updates Full-Year 2022 Financial Guidance

  8/11/2022

  Bioventus Inc. today reported financial results for the three and six months ended July 2, 2022.

• Innovation1 Biotech Appoints Chief Scientific Officer Andrew L. Salzman, M.D. to its Board of Directors

  8/11/2022

  Innovation1 Biotech Inc. today announced the appointment of the Company’s Chief Science Officer, Andrew L. Salzman, M.D., to its Board of Directors.

• AN2 Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Updates

  8/11/2022

  AN2 Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, reported financial results for the quarter ended June 30, 2022.

• Cingulate Inc. Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update

  8/11/2022

  Cingulate Inc. announced its financial results for the quarter ended June 30, 2022, and provided a clinical and business update.

• Inspira™ Technologies Reports Second Quarter 2022 Financial Results

  8/11/2022

  Inspira Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a groundbreaking respiratory support technology company, announced today its financial results for the second quarter ended June 30, 2022.

• North America and Europe Preclinical Medical Device Testing Services Market Size, Report 2022-2030

  8/11/2022

  The North America and Europe preclinical medical device testing services market was surpassed at USD 1.4 billion in 2021 and is expected to hit around USD 2.99 billion by 2030, growing at a CAGR of 8.8% from 2022 to 2030

• OceanTech Acquisitions I Corp. and Captura Biopharma, Inc. Announce Signing of Definitive Business Combination Agreement

  8/10/2022

  Captura Biopharma, Inc. is developing oral chelators for the treatment of internal transuranic radionuclide contamination and heavy metal poisoning.

• Versant Ventures Launches Vector BioPharma AG

  8/10/2022

  Versant Ventures today announced the debut of Vector BioPharma AG, a biopharmaceutical company developing a precision gene delivery platform that is devoid of viral genes.

• IsoPlexis Reports Second Quarter 2022 Financial Results

  8/10/2022

  IsoPlexis Corporation today reported financial results for the quarter ended June 30, 2022.

• HilleVax Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress

  8/10/2022

  HilleVax, Inc. reported financial results for the quarter ended June 30, 2022, highlighted recent program progress, and outlined key upcoming milestones for HIL-214, the company’s investigational virus-like particle based vaccine for the prevention of moderate-to-severe norovirus-related acute gastroenteritis.

• iNtRON developed New CRISPR/Cas technology specific for Bacteriophage as PHAGERUS® Platform

  8/10/2022

  iNtRON Biotechnology announced that iNtRON has developed its unique CRISPR/Cas system customized for the genetic modification of certain bacteria and corresponding bacteriophage.

• Serum Separation Gel Market: Increase in Number of Blood Banks Across Globe to Drive the Market

  8/10/2022

  Wilmington, Delaware, United States, Transparency Market Research Inc. – Serum separation gel enables the stable and reliable separation of the blood clot and serum with low influence on the clinical results.

• Cardiac Biomarker Diagnostic Kits Market is Growing at a CAGR of 5.2% from 2022 to 2030

  8/10/2022

  According to the report, the global cardiac biomarker diagnostic kits market was valued at US$ 2.2 Bn in 2021 and is anticipated to grow at a CAGR of 5.2% from 2022 to 2030

• Indwelling Catheters Market Research Report 2022to 2030

  8/10/2022

  The demand for high quality patient care is surging in the U.S. healthcare landscape.

• PCR & Real-time PCR Molecular Diagnostics Market Size to Surpass US$ 6.5 Bn by 2030

  8/10/2022

  According to the report, the global PCR & real-time PCR molecular market was valued over US$ 4.1 Bn in 2021.

• BAUSCH HEALTH ANNOUNCES SECOND-QUARTER 2022 RESULTS

  8/9/2022

  Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health" or the "Company" or "we" or "our") today announced its second-quarter 2022 financial results.

• Aziyo Biologics Co-Founder and Regenerative Medicine Pioneer, Dr. Randy Mills, appointed Chief Executive Officer

  8/9/2022

  Aziyo Biologics, Inc., a commercial-stage regenerative medicine company, announced that Aziyo co-founder C. Randal Mills, Ph.D. has assumed the President and Chief Executive Officer role on an on-going basis.

• Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results

  8/8/2022

  Nyxoah SA, a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, reported financial and operating results for the second quarter and first half of 2022.

• Ornithine Transcarbamylase (OTC) Deficiency Treatment Market Size, Report 2022 to 2030

  8/8/2022

  The global ornithine transcarbamylase (OTC) deficiency treatment market was valued at US$ 600 Mn in 2021. It is projected to expand at a CAGR of 4% from 2022 to 2030.